Podcasts about Pritt

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the value laboratories deliver for their entire health system. They cover how laboratories impact:Growth in revenueGrowth in lab chargesGrowth in ancillary servicesHospital length of stayControl over expensesYou can also find more in-depth information on this topic in “Maximizing your health system's financial performance,” a white paper with data-driven ways laboratories support their organizations. 

In this episode of "Lab Medicine Rounds," we explore how to navigate the often-tricky terrain of giving and receiving feedback. Join the conversation as we unpack common pitfalls, reframe defensive reactions, and offer practical tools for fostering growth-minded, judgment-free dialogue. Whether you're leading a team or developing your own feedback skills, this episode offers thoughtful insights you can use right away.  

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss tick-borne diseases. They cover:Different diseases patients can get from ticks. Disease prevention, including Dr. Pritt's A through Z flash cards with tips for people to protect themselves from infectious insects.Laboratory medicine's valuable role in testing and educating providers to diagnose patients quickly and accurately.Clinical areas most likely to encounter patients with tick-borne diseases.Reliable sources for details about the prevalence of different diseases around the country (e.g., U.S. Centers for Disease Control and Prevention (CDC) and Mayo Clinic Laboratories).

On this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., speaks with Erinn Downs, D.O., professor of laboratory medicine and pathology at Mayo Clinic's Arizona campus, on the topic of benign mimics of malignant breast pathology.

In this episode of “Answers From the Lab,” William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, is joined by Russ Lebovitz, M.D., Ph.D., CEO and co-founder of Amprion. They discuss their strategic collaboration and the innovative SAAmplify™–αSYN (CSF) test. They covered: Details about how the cerebrospinal fluid biomarker test (Mayo ID: ASYNC) benefits patients exhibiting signs and symptoms of clinically uncertain cognitive decline or clinically uncertain Parkinsonian syndromes.Groundbreaking science on proteins that Amprion leveraged to create a solution that meaningfully impacts patient care and provides value to clinicians.Information physicians receive from the test, and when they should consider ordering it for their patients. Opportunities to change diagnostic journeys by providing accurate, early diagnosis with SAAmplify–αSYN. 

In this episode of Lab Medicine Rounds, Justin Kreuter, M.D., and Miglena Komforti, D.O., from Mayo Clinic as they discuss threshold diagnoses of the breast — those gray zones that challenge even seasoned professionals. Learn why they're important, how to approach them, and what role technology might play in the future. 

Paul Jannetto, Ph.D., explains how Mayo Clinic Laboratories' SPAS test identifies the form of arsenic present in patients with arsenic exposure. That information is important for determining the potential level of harm and for removing the patient from the arsenic source to ease symptoms and prevent cancer risk.Speaker 3: (00:33) Do you mind telling us a little bit about yourself and your background? Speaker 3: (01:45)Could you please provide us with an overview of arsenic, how people get exposed, and the laboratory testing for arsenic and arsenic speciation? Speaker 3: (05:25)Which patients should have this testing, and when should it be performed? Speaker 3: (06:57)What alternative test options are available, and how does testing at Mayo Clinic compare? Speaker 3: (08:37)How are the results used in patient care?

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the recent court judgment on the U.S. Food and Drug Administration's (FDA) oversight of lab-developed tests (LDT). They covered:  Details about the ruling to vacate the FDA's rule on LDT oversight. What LDT oversight might look like in the future. How the laboratory medicine industry can help create an oversight approach that is positive for both patients and innovation. 

Jessica Wright, Pharm.D., BCACP, explains how Mayo Clinic Laboratories' 3A5Q test helps determine initial tacrolimus doses for individuals after organ transplants. Optimal doses can vary by patient ethnicity and are key to successful transplantation.Speaker 3: (00:32) Could you provide us a with little bit about your background and yourself? Speaker 3: (03:45) Will you please provide a brief overview of Mayo test 3A5Q? Speaker 3: (06:56) Which patients should have this testing, and when should it be performed? Speaker 3: (08:15) What alternative or complementary tests should be considered? Speaker 3: (09:25)How are the results used in patient care? Speaker 3: (10:38)Will you help the audience understand the significance of monitoring tacrolimus levels for transplant rejection? Speaker 3: (12:53)What alleles are included in this test?

As we approach Lab Week, this episode of “Lab Medicine Rounds” includes a compilation of interviews from previous episodes highlighting the pivotal role laboratory professionals play in healthcare. Featured interviews include Dr. Eric Hsi, Dr. Curt Hanson, and Jane Hermansen, all from Mayo Clinic in Rochester, Minnesota.Discussion includes:·       The importance of highlighting the laboratory presence in current medical practice.·       How laboratory medicine is informing the future successes of the field.·       Wishes for the future of laboratory medicine and pathology.Timestamps:00:30: Interview w/Dr. Hsi·       Why is it important to highlight the presence of the laboratory in current medical practice?·       What would be your advice for clinicians who haven't thought about the role the laboratory plays, and how to bring it more explicitly into their practice?·       Where is the laboratory headed? ·       What do you think might be the biggest challenge in stepping forward into more of the clinical domain?05:32: Interview w/Dr. Hanson·       Why is it important in lab medicine to look at the past when planning for the future?·       How do you see certain aspects of laboratory medicine informing the future successes of the field?·       How do we as laboratory professionals, shift from being service-oriented to being colleagues/equals with other health care professionals?07:45: Interview w/Jane Hermansen·       What do you wish for the future of laboratory medicine and pathology?

In this episode of “Answers From the Lab,” William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, invited Min-Han Tan, M.B.B.S., FRCP, Ph.D., founding CEO and medical director of Lucence, to discuss liquid biopsy cancer testing. Mayo Clinic Laboratories and Lucence recently announced a collaboration to expand access to this cutting-edge cancer test that is designed to detect clinically relevant biomarkers in ctDNA and ctRNA.During their conversation, Dr. Morice and Dr. Tan explore:Inspiration for developing the liquid biopsy.Features that differentiate LiquidHALLMARK® from existing cancer tests.Patients who will benefit from the test and how an oncologist might use the results.The future potential of liquid biopsy advancements.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the evolution of retail health. They cover several key topics, including:The emergence of retail health locations.Three types of care that are well-suited for a retail approach to healthcare.The importance of incorporating diagnostics when designing retail health.Keep up with the latest diagnostic news and Dr. Morice's insights on LinkedIn and X. 

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss infectious disease activity around the nation. They cover:    The high prevalence of influenza A, avian influenza, measles, and COVID-19. Reliable resources for information on the spread of infectious diseases. Prevention measures and their impact on the spread of infectious diseases. The risks associated with multiple infectious diseases circulating simultaneously at high rates. 

On this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., speaks with senior associate dean of academic affairs for Mayo Clinic Alix School of Medicine, Joseph Maleszewski, M.D., on the future of basic sciences in medical education.Discussion includes:·       Challenges of basic science in medical education.·       Differing perspectives about basic science in medical education.·       Ideas of exploration for the future.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Elitza Theel, Ph.D., director of the Infectious Diseases Serology Laboratory at Mayo Clinic, for a conversation about innovation in testing for sexually transmitted infections (STI). Topics include: The advantages and challenges of new types of specimen collection and testing methods, including over-the-counter, at-home, and point-of-care options. Implications home testing has for clinicians and public health. Barriers to making more at-home collection and over-the-counter testing products for STI testing.The growing need for tests to detect resistance markers as antimicrobial resistance increases. 

It's Budget speech season, and Finance Minister Enoch Godongwana is cracking his whip. That's why Darren's Sky, and Carmen asked: Which item should never increase in price? Despite the obvious things like bread and fuel, Roman is outraged by the price of speckled eggs, and one mum from Queensburgh can't believe the price of Pritt! Webpage

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, for a conversation about quality management. Specifically, they discuss: The benefit of investing in quality management for patients, staff, and the organization.How Mayo Clinic's Department of Laboratory Medicine and Pathology in Rochester evolved and grew its quality management program.The advantage of holding 5–10-minute huddles each day.How the lab leverages education on quality tools and Gemba Walks to empower all staff to invest in quality management.

On this episode of “Lab Medicine Rounds,” Just Kreuter, M.D., chats with Jennifer Boland Froemming, M.D., about creating the perfect rank list for training programs. Dr. Boland Froemming shares her insights and tips to help you make informed decisions.Discussion Includes:00:36 How rank lists work.03:45 What to consider when making a rank list.06:20 Recommendations for individuals applying to training programs.

PJ speaks about the stress of taking on a new part-time job as a barista and Kevin tells him that his life would be easier if he didn't throw out manuals. For the theme they discuss art in all its iterations; from primary school frustrations of never being able to draw, to feeling guilty on city trips when letting out a yawn in revered galleries and exhibitions. They also give a special shout out to the one man who went above and beyond really tried to instil a love of art in millennials but was too quick to whip out the PVA glue - Neil Buchanan from Art Attack.NEW 2025 IRISH DATES ADDED FOR THAT'S SHOWBIZ ⭐️ TICKETS HERE: https://www.ticketmaster.ie/i-m-grand-mam-tickets/artist/5450389Sign up to the I'm Grand Mam Patreon for more stunning content: https://www.patreon.com/imgrandmam ✨ Hosted on Acast. See acast.com/privacy for more information.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss recent business trends in diagnostics and why it is important for pathologists to stay informed about these trends. Their conversation covers: What's driving a renewed interest in investing in diagnostics.Why the knowledge pathologists have is so valuable in the current landscape.How the evolving expectations of laboratory professionals will make it important to stay informed about business trends.

In this month's episode of Lab Medicine Rounds, Justin Kreuter, M.D., speaks with Monica Ibarra about the essential role of diversity, equity, and inclusion in healthcare and beyond. Timestamps:0:00 Introduction0:43 Why conversations about diversity are important3:56 Common challenges that arise during discussions6:11 Approaching conversations in different environments11:17 Leaders navigating challenging DEI conversations20:00 Diversity reflection questions to ask yourself

Sanjeev Sethi, M.D., Ph.D., explains how Mayo Clinic Laboratories' new mass spectrometry test (Mayo ID: MSMN) identifies most antigens now known to cause membranous nephropathy. Precise identification of antigens is important for optimal management of this serious kidney disease.Speaker 3: (00:32) Would you mind telling us a little bit about yourself and your background? Speaker 3: (01:58) Would you give us an overview of membranous nephropathy?  Speaker 3: (07:14) Could you tell us a little bit about this new assay? Speaker 3: (14:29) Could you give a little example of how a clinician might use this information to treat their patients differently than how they would've in the past?   

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss Dr. Morice's recent article in Becker's Hospital Review, “Nine Developments Predicted to Shape Laboratory Medicine and Diagnostics in 2025,” and go deeper into conversation about: The rapid evolution of artificial intelligence and large language models.Digital pathology.Proteomics, metabolomics, and mass spectrometry.

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., speaks with Kristen Ruby, D.O., M.P.H., to discuss National Blood Donor Month and the impact blood donors make. Timestamps:00:00 Introduction00:47 Celebrating blood donors03:43 Types of blood donors11:16 Diversity of blood inventory17:17 Thank you19:22 Outro

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Erin Graf, Ph.D., co-director of Microbiology in the Department of Laboratory Medicine and Pathology at Mayo Clinic in Arizona, to discuss benefits of automation in the laboratory.   Topics of discussion include:Specific examples of how they are using automation in the laboratory. Strategies for ensuring a smooth implementation and a positive experience for staff. The potential of automation to support staff and continued patient care excellence amid projected labor shortages in the future. 

It's your turn...to click here to send us your comments on the showAdrian takes the first player token and kicks off 2025 with a new episode all about pasted on themes, when they get in the way, when they don't and our general thoughts about them.FIRST PLAYER: AdrianOTHER PLAYERS: Becky, Davey & RobIn this episode you'll learn:- that Becky has been playing the game of organising Florida trips- Davey talks about the new "Duel" in town with Lord of the Rings: Duel for Middle-Earth by Repos Production- Rob is getting his RPG on with some classic D&D- Does Adrian get his solo fix in Final Girl by Van Ryder Games?- all about the groups experiences with themes and whether they help, hinder or whether anyone really cares about theme.LINKS REFERENCED IN THE SHOWN/AEPISODE CHAPTERS0:00 - TURN 1 - Player Count1:35 - TURN 2 - Let's Talk About Hex1:58 - Becky - Organising Disney World Holidays5:10 - Davey - Lord of the Rings: Duel for Middle-Earth10:15 - Rob - D&D14:08 - Adrian - Final Girl21:32 - TURN 3 - Main Event: Pritt Stick Themes - Is theme important and if so why?29:47 - The benefits of when theme sticks to mechanics37:42 - What connects a theme to a game?49:58 - What doesn't connect themes to games?1:01:46 - TURN 4 - Receive, Sleeve or Leave1:10:18 - TURN 5 - Penultimate Turn: What's Coming Up1:16:38 - TURN 6 - The Final TurnSupport the showSUPPORTING THE SHOW- Support us on Ko-FiENGAGING WITH THE SHOWWe want your questions so engage with the show through our channels below:- Email Us - BoardGameGeek - Facebook - Instagram- Youtube - TikTok

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss emerging concerns about H5N1 avian influenza. Specific topics of discussion include:Patterns of transmission and what they indicate about the potential of person-to-person transmission. Tools, tests, and processes that emerged in recent years that are making it easier to understand and track this virus. Remaining unknowns about the virus and how it could evolve. 

In this episode of Lab Medicine Rounds, Justin Kreuter, M.D., speaks with education specialist Bob Jackson on the challenges and importance of being a lifelong learner. Timestamps:00:00 Introduction00:31 Importance of lifelong learning02:03 Challenges of lifelong learning06:07 Adapting to change10:58 Teaching and learning13:39 Embracing uncertainty17:00 Encouraging lifelong learning24:00 New Year's resolutions

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the progress of artificial intelligence (AI) and what's next in this space.Specific topics of discussion include:What's driving the rapid acceleration of AI advancements.Ethical concerns and opportunities.How expenses, payment models, and culture influence AI advancements.The need to rethink training and education amid the rise of AI solutions.

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., speaks with medical students on the importance of understanding healthcare systems, their experiences from a global surgery hackathon, and how maintaining curiosity and continuous learning can enhance their medical practice.Timestamps:0:00 Introductions0:49 Importance of Understanding Healthcare Systems1:33 Fundamentals of Healthcare Systems3:03 Complexity of Healthcare Systems5:13 Selective vs Curriculum6:08 Systems and Inequalities7:18 Billing and Economics in Healthcare8:17 Balancing Medical Training and System Knowledge9:01 Curiosity and Continuous Learning10:02 Learning Opportunities13:02 Slowing Down in Critical Phases16:41 Revising Healthcare Systems18:02 Capturing Learning22:03 Maintaining Curiosity24:01 Advice for Developing Skills in Healthcare Systems

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss the latest in infectious disease outbreaks.    Specific topics of discussion include:Recent trends in the spread of H5 bird flu and dengue fever. Why it's important to think globally when monitoring infectious diseases.Extra precautions to take during the holiday travel season to keep you and those around you healthy.

In this episode of Lab Medicine Rounds, Justin Kreuter, M.D., speaks with career educator Elissa Hall, Ed.D., on the integration and impact of artificial intelligence in graduate medical education, exploring strategies for teaching AI, the importance of critical thinking, and the ethical considerations involved.Timestamps0:00 Intro01:07 Graduate medical education and artificial intelligence03:20 How to use AI to develop physician skills. 05:00 Educational strategies for training in AI?08:21 Training with AI look12:22 How to be a critical thinker14:24 Assessment with AI education17:40 How to use AI in clinical practice 21:25 Outro

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss how labs can enhance patient access to improve health equity.Specific topics of discussion include:Innovations creating new possibilities, such as mobile clinics, at-home tests, and artificial intelligence.The responsibility of laboratory professionals to help guide the use of these new tools and the importance of collaboration between health systems.What's needed to make solutions scalable and sustainable.Learn more in Dr. Morice's “Lab Manager” article. 

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by genetic counselors Carrie Lahner, M.S., CGC, and April Studinski Jones, M.S., CGC, to discuss how family medical history can inform genetic testing strategies.   Specific topics of discussion include:The seven main types of genetic testing, and how clinicians know when and what genetic testing to order.Key family history details to collect to inform decisions about genetic testing. How genetic counselors collaborate with physicians and laboratorians to make testing decisions. Recent genetic testing advancements that are improving diagnostics. 

John Logan Black, M.D., explains how Mayo Clinic Laboratories' UGT1A1 tests (Mayo IDs: U1A1Q and UGTFZ) identify genetic variants that increase the risk of potentially life-threatening reactions to irinotecan, a chemotherapy agent.Speaker 3: (00:32) Could you give us a brief overview about your background and yourself? Speaker 3: (02:16) Could you explain the role of the UGT1A1 gene and its significance in the pharmacogenomics of irinotecan?  Speaker 3: (05:34) What specific tests do we offer for UGT1A1 at Mayo Clinic Laboratories? Speaker 3: (08:01) Can you clarify the difference between targeted genotyping and full gene sequencing, and when each method is most appropriate? Speaker 3: (10:36)Could you elaborate on the specific clinical indications for testing in relation to irinotecan? Speaker 3: (13:27) How do UGT1A1 test results impact the dosing of irinotecan? What should clinicians consider when using those results?  Speaker 3: (14:02) Are there any other factors or related genes that should be considered alongside UGT1A1, particularly for cancer therapy?

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., interviews John Sherbeck, M.D., Laboratory Medical Director of Trinity Health IHA Medical Group, about how to plan your time at medical conferences. He also briefly discusses this year's takeaways from AABB's national conference.Timestamps:0:00 Intro00:45 Why are medical conferences important to attend?03:10 Engaging in debate05:11 Prepping your team to present at a national conference06:40 Take aways from the AABB annual meeting?09:57 When you attend a conference, how do you go about planning out your time?12:57 How do you approach networking?15:05 What is your current practice for approaching vendors?17:18 How do you capture your conference learning?19:50 Outro

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss recent outbreaks in vaccine-preventable diseases.  Specific topics of discussion include:Recent increases in outbreaks of infectious diseases, such as pertussis, measles, and polio. The serious side effects of the diseases. What's fueling the resurgence of these diseases.Testing options for infectious diseases and resources for physicians.

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., interviews Timothy Long, M.D., about the importance of asking good questions in healthcare settings, such as when you're with patients, as an educator, or at a conference or presentation.  Timestamps:00:00 Introduction01:58 Developing the skill of asking good questions06:37 Characteristics of effective questions11:45 Effectively using questioning techniques as an educator15:33 Considerations for asking questions in large group settings

While confirmed cases for many respiratory illnesses are currently low, they will almost certainly spread as we move further into fall and winter. Now is the perfect time to prepare and take steps to protect yourself from everything from COVID-19 and influenza to RSV and the common cold. In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, to discuss practical steps for protecting yourself and innovations that are making testing and vaccination easier. Specific topics of discussion include:The importance of vaccinations and preventive measures to keep you healthy. Innovations that are making it possible to provide more at-home options for vaccination and testing and when these options will be most beneficial. The latest status on avian influenza.

Pritt is back from a long hiatus. We talk the current state of the program. Head coaching candidates. And Preview Arizona. --- Support this podcast: https://podcasters.spotify.com/pod/show/mojacks/support

Megan Hoenig, M.S., M.P.H., CGC, explains how Mayo Clinic Laboratories' unique hypermethylation analysis (Mayo ID: MLHPB) provides critical adjunct information for managing Lynch syndrome. That genetic condition increases patients' risk for many kinds of cancer.Speaker 3: (00:32) Could you provide our listeners with a little bit about yourself and your background? Speaker 3: (01:27) Could you give an overview of our MLH1 hypermethylation, also referred to as MLHPB in our test catalog?  Speaker 3: (02:48) Can you talk about why your team thought it was really important to develop this test? Speaker 3: (04:03) What patients would this testing really benefit? Speaker 3: (06:10)How are the results used in patient care? Speaker 3: (07:56) Anything else you would like our listeners to hear about MLHPB?

From cyberattacks to utility failures, technology disruptions are a growing risk in an increasingly digitized and automated laboratory environment. Planning for technology disruptions positions laboratories to embrace the full power of automation, artificial intelligence, and digitization while still meeting critical patient care needs during an outage. In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by John Osborn, operations administrator in the Department of Laboratory Medicine and Pathology at Mayo Clinic, who helps lead efforts to prepare for technology disruptions in the laboratory. Specific topics of discussion include:Immediate considerations when a technology disruption occurs and prioritizing the restoration of systems and processes. How to create strategies and tools to guide decision-making and operations amid multiple outage scenarios. Lessons learned from real life examples, including the importance of clear communication, empowering lab directors to make decisions, and pre-planning for recovery. Preventive measures and risk mitigation strategies you can take today to make it easier to respond during a future incident.

In this episode of “Lab Medicine Rounds,” Justin Kreuter, M.D., interviews Reade Quinton, M.D., an associate professor of laboratory medicine and pathology and anatomic pathologist at Mayo Clinic, to discuss interview tips for future pathology residents. Timestamps:0:00 Introduction0:45 Interviewer assessment7:07 Communication style & personality10:25 Asking questions to help with rank lists17:45 Follow-up after interview22:09 Outro

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Alicia Algeciras-Schimnich, Ph.D., a professor of laboratory medicine and pathology at Mayo Clinic and co-director of the Clinical Immunoassay Laboratory. They discuss Mayo Clinic's plasma test for detecting Alzheimer's disease and how it supports increased access and early detection. Specific topics of discussion include:The phospho-Tau 217 plasma test (Mayo ID: PT217) used to evaluate individuals aged 50 years and older with symptoms of cognitive impairment who are being assessed for Alzheimer's disease and other causes of cognitive decline.The benefits of a blood test versus the other diagnostic methods for Alzheimer's disease.Why early diagnosis is so important for quality of life and treatment planning.How tests like Mayo Clinic Laboratories' PT217 may change the landscape of Alzheimer's research and treatment.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by Dong Chen, M.D., Ph.D., chair of the Division of Hematopathology in the Department of Laboratory Medicine and Pathology at Mayo Clinic. They discuss rare and inherited platelet disorders and esoteric laboratory testing of hematologic disorders.Specific topics of discussion include:How these rare disorders are diagnosed through laboratory tests.Why platelet transmission electron microscopy is considered the gold standard for diagnosing disorders like Hermansky Pudlak syndrome, Wiskott-Aldrich syndrome, Chediak Higashi syndrome, and Jacobson/Paris-Trousseau syndrome.The process involved with developing and validating the PTEM test (Mayo ID: PTEM) at Mayo Clinic.The importance of ongoing research and advocacy to enhance care for patients with rare platelet disorders.

In this episode of “Answers From the Lab,” host Bobbi Pritt, M.D., chair of the Division of Clinical Microbiology at Mayo Clinic, is joined by William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories. They discuss the latest news in pathogen activity and how these viruses serve as an important reminder of the role of the public-private lab partnership.Their discussion includes:How the United States addresses emerging pathogens and the importance of a partnership between public health laboratories and private or clinical laboratories.Why access to testing is vital to prevent pathogen outbreaks and pandemics.The need for an effective legal framework around pandemic and hazard preparedness.Current diagnostic efforts around mpox, bird flu, and COVID-19, and opportunities to expand at-home testing.

Matthew Schultz, Ph.D., and Amy White, M.S., CGC, explain how Mayo Clinic Laboratories' unique urine assay (Mayo ID: SORD) screens for peripheral neuropathy arising from SORD gene variants. Although recently identified, SORD-related peripheral neuropathy is fairly common.(00:31) Would you share a little bit about yourself and your background? (01:11) Could you provide us with an overview of this particular peripheral neuropathy?  (03:09) Can you share the background as to how your team learned about this condition and how you considered testing for it? (04:42)Would you explain what you saw when you performed the urine test on the first patient? (05:26) Were you able to test additional patients with this condition? (06:09)Could you expand on why this urine test is important? (07:20) How does a health care provider order urine testing for SORD deficiency? (07:59) How does this new SORD urine test complement the existing Mayo Clinic Laboratories test menu? (08:55)Could you summarize the benefits of ordering this SORD urine test at Mayo?

In this episode of “Answers From the Lab,” William Morice II, M.D., Ph.D., CEO and president of Mayo Clinic Laboratories, is joined by special guest Donald Thomas, M.D., a rheumatologist and lupus researcher. They discuss how Mayo Clinic Laboratories' suite of innovative lupus testing, offered in collaboration with Progentec Diagnostics, is enhancing the care and quality of life for patients affected by systemic lupus erythematosus (SLE).Their discussion includes:Symptoms of lupus and characteristics of the complex disease process.The role of laboratory testing in diagnosing and managing long-term treatment for patients with lupus.Dr. Thomas' clinical experience using the Progentec aiSLE® DX Lupus Flare Risk Index and Lupus Disease Activity Index for his patients, and how these tests have enhanced collaborative treatment planning.Why these novel tests are a major step forward in expanding diagnostic tools and improving care for patients living with SLE.

John Mills, Ph.D., and Divyanshu Dubey, M.B.B.S., explain how Mayo Clinic Laboratories' new test panel can distinguish among various potential causes of demyelinating neuropathies. Test results are important for managing these devastating autoimmune conditions.Show notesSpeaker 3: (00:32) Would you provide a little background on yourself, Dr. Mills? Speaker 3: (01:19) Dr. Dubey? Speaker 3: (02:07) Can you give a brief overview of our demyelinating test and recommended use? Speaker 3: (03:52) Can you discuss how this new test will assist in a patient's journey? Speaker 3: (05:46) Can you tell us some of the unique features of this test? Speaker 3: (08:09) Dr. Dubey, as a neurologist, how does this test set us apart in the market? Speaker 3: (11:05) Could you summarize the benefits of having both a demyelinating panel and an axonal panel? Speaker 3: (11:40) Why should a patient have an axonal or demyelinating test versus a sensory and motor test for peripheral neuropathy?

An Occupational Therapist assistant by trade, Kacie Pritt, Regional Director of Development of HCF Management and BTG Ambassador, shares first-hand tactics and strategies for building occupancy in skilled nursing facilities. Produced by Solinity Marketing.Sponsored by Accushield, Aline, NIC MAP Vision, Procare HR, Sage, Hamilton CapTel, Service Master, The Bridge Group Construction and Solinity. Become a sponsor of Bridge the GapConnect with BTG on social media:YouTubeInstagramFacebookTwitterLinkedInTikTokMeet the Hosts:Lucas McCurdy, @SeniorLivingFan Owner, The Bridge Group Construction; Senior Living Construction Renovation, CapEx, and Reposition. Joshua Crisp, Founder and CEO, Solinity; Senior Living Development, Management, Marketing and Consulting.